Comparative Assessment of CMR-Determined Extracellular Volume Metrics in Predicting Adverse Outcomes.

Extracellular volume (ECV) by cardiovascular magnetic resonance (CMR) imaging is associated with disease burden and clinical outcomes. Recent studies in patients with valvular heart disease (VHD) have suggested that the indexed total ECV (iECV) = ECVx(LV/1.05)/body surface area may supersede ECV in terms of prognostication.

His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant Variant.

Variant transthyretin amyloidosis cardiomyopathy (ATTRv-CM) is a rare form of cardiac amyloidosis associated with many possible mutations in the transthyretin gene, presenting as various distinct clinical phenotypes. Among these, the His108Arg mutation is the most prevalent TTR variant in Austria. However, data describing its clinical phenotype are lacking.

Laser-Induced Metal-Organic Framework-Derived Flexible Electrodes for Electrochemical Sensing.

The successful development of a metal-organic framework (MOF)-derived Co/CoO/C core-shell composite integrated into laser-induced graphitic (LIG) carbon electrodes for electrochemical sensing is reported. The sensors are fabricated via a direct laser scribing technique using a UV laser (355 nm wavelength) to induce the photothermolysis of rationally selected ZIF-67 into the LIG matrix. Electrochemical characterization reveals that the incorporation of the laser-scribed ZIF-67-derived composite on the electrode surface reduces the impedance more than 100 times compared with bare LIG sensors.

Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis.

Aims: Quantification of cardiac [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake enhances diagnostic capabilities and may facilitate prognostic stratification in patients with transthyretin cardiac amyloidosis (ATTR-CA). This study aimed to evaluate the association of quantitative left ventricular (LV) DPD uptake with myocardial structure and function, and their implications on outcome in ATTR-CA.

Methods And Results: Consecutive ATTR-CA patients (n=100) undergoing planar DPD scintigraphy with Perugini grade 2 or 3, alongside quantitative DPD SPECT/CT imaging and speckle-tracking echocardiography between 2019 and 2023, were included and divided into two cohorts based on median DPD retention index (low DPD uptake: ≤5.